The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

A University of Alberta-led study has put to rest a long-standing controversy about the best time of day to take blood ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

As the FDA halts the sale of Ozempic and Zepbound copycats, online clinics have begun offering liraglutide, an older GLP-1 ...

The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, ...

The drug comes as an inhaler that’s typically used once per day. Breo Ellipta specifically treats: asthma in adults and children ages 5 years and older chronic obstructive pulmonary disease ...

Treatment with cenobamate may reduce seizure frequency among patients with drug-resistant epilepsy after 3 months.

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at ...

President Donald Trump signed an executive order Monday that aims to coax pharmaceutical companies into offering lower prices in the United States, taking a historically broad swipe at the cost of ...

NEW YORK, May 12 (Reuters) - President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices ... supplements for children from market 7:49 PM ...

The Food and Drug Administration's approval in 2023 of lecanemab - a novel Alzheimer's therapy shown in clinical trials to modestly slow disease progression - was met with enthusiasm by many in the ...

AbbVie ABBV announced that the FDA has granted accelerated approval to its antibody-drug conjugate (ADC), telisotuzumab ...